3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
15
Breast Neoplasms
13
Leukemia, Myeloid, Acute
11
Carcinoma, Non-Small-Cell Lung
11
Glioblastoma
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
8
Brain Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Mantle-Cell
7
Leukemia
7
Multiple Myeloma
6
Hodgkin Disease
6
Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, T-Cell, Cutaneous
5
Lung Neoplasms
5
Gliosarcoma
5
Congenital Abnormalities
5
Breast Neoplasms, Male
5
Recurrence
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Immunoblastic Lymphadenopathy
4
Interventions
Paclitaxel
22
Carboplatin
18
liposomal doxorubicin
14
Bevacizumab
9
Topotecan
8
Docetaxel
8
Gemcitabine
7
Cisplatin
7
rucaparib
6
pembrolizumab
6
mirvetuximab soravtansine
5
Cyclophosphamide
5
Taxes
4
Albumin-Bound Paclitaxel
4
sargramostim
3
ixabepilone
3
Cytoreduction Surgical Procedures
3
CCV-AV protocol
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
pazopanib
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
denileukin diftitox
2
cediranib
2
catumaxomab
2
belinostat
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ovarian Epithelial
×
Vorinostat
×
Clear all
No trials found.